Source: http://www.google.com/patents/US20090204163?dq=5920316
Timestamp: 2016-09-27 03:42:51
Document Index: 417512688

Matched Legal Cases: ['Application No. 61', 'art 22', 'art 22', 'art 22', 'art 22', 'art 22', 'art 22', 'art 22', 'art 22', 'art 22', 'art 22', 'art 22', 'art 22', 'art 22', 'art 22', 'art 22']

Patent US20090204163 - Methods of monitoring hemodynamic status for rhythm discrimination within ... - Google PatentsSearch Images Maps Play YouTube News Gmail Drive More »Sign inPatentsSystems and methods of performing rhythm discrimination within a patient's body using sensed hemodynamic signals are disclosed. The method can include the steps of receiving an electrical activity signal from an electrode located within or near the heart, detecting an event of the heart based on the...http://www.google.com/patents/US20090204163?utm_source=gb-gplus-sharePatent US20090204163 - Methods of monitoring hemodynamic status for rhythm discrimination within the heartAdvanced Patent SearchTry the new Google Patents, with machine-classified Google Scholar results, and Japanese and South Korean patents.Publication numberUS20090204163 A1Publication typeApplicationApplication numberUS 12/366,334Publication dateAug 13, 2009Filing dateFeb 5, 2009Priority dateFeb 11, 2008Also published asEP2242538A2, EP2242538B1, US8725260, WO2009102613A2, WO2009102613A3Publication number12366334, 366334, US 2009/0204163 A1, US 2009/204163 A1, US 20090204163 A1, US 20090204163A1, US 2009204163 A1, US 2009204163A1, US-A1-20090204163, US-A1-2009204163, US2009/0204163A1, US2009/204163A1, US20090204163 A1, US20090204163A1, US2009204163 A1, US2009204163A1InventorsAllan C. Shuros, Dan Li, Quan NiOriginal AssigneeShuros Allan C, Dan Li, Quan NiExport CitationBiBTeX, EndNote, RefManPatent Citations (102), Referenced by (26), Classifications (6), Legal Events (1) External Links: USPTO, USPTO Assignment, EspacenetMethods of monitoring hemodynamic status for rhythm discrimination within the heart
US 20090204163 A1Abstract
receiving an electrical activity signal from an electrode located within or adjacent to the heart; detecting an event of the heart based at least in part on the electrical activity signal; receiving a mechanical activity signal from a sensor located in or adjacent to the heart, the sensor configured to sense both atrial contraction and ventricular contraction within the heart; analyzing a mechanical activity signal received from the sensor; and confirming an event based at least in part on the mechanical activity signal. 2. The method of claim 1, further comprising providing therapy to the patient based at least in part on the type of event confirmed.
providing an implantable medical device including a control unit adapted to run an algorithm for detecting arrhythmia events within the heart; receiving an electrical activity signal from an electrode located within or adjacent to the heart; detecting an arrhythmia event of the heart based at least in part on the electrical activity signal; sensing one or more pressure measurements associated with the atrial contraction and ventricular contraction of the heart using a pressure sensor implanted within a pulmonary artery of the patient; confirming the event based at least in part on a sensed pressure signal received from the sensor; and providing a therapy to the patient if the event is positively confirmed. 13. The method of claim 12, wherein analyzing the pressure signal received from the sensor includes comparing a right atrial contraction rate to a right ventricular contraction rate.
an electrode configured to sense electrical activity of the heart; a mechanical sensor implanted in or adjacent to the heart, the sensor configured to sense both atrial and ventricular contraction of the heart; and an implantable medical device in communication with the sensor, the implantable medical device configured to provide therapy to the patient based at least in part on a sensed mechanical activity signal received from the sensor and an electrical activity signal received from the electrode. 19. The system of claim 18, wherein the mechanical sensor is a pressure sensor.
[0001] This application claims priority under 35 U.S.C. � 119 to U.S. Provisional Application No. 61/027,683, filed on Feb. 11, 2008, entitled “Methods Of Monitoring Hemodynamic Status For Rhythm Discrimination Within The Heart,” which is incorporated herein by reference in its entirety.
[0002] The present disclosure relates generally to the field of implantable medical devices. More specifically, the present disclosure pertains to systems and methods of monitoring hemodynamic status for rhythm discrimination within a patient.
[0003] Implantable medical devices (IMDs) such as pacemakers and implantable cardioverter defibrillators are utilized in monitoring and regulating various conditions within the body. An implantable cardioverter defibrillator, for example, is often utilized in cardiac rhythm management applications to monitor the rate and rhythm of the heart and for delivering various therapies such as cardiac pacing, cardiac defibrillation, and/or cardiac therapy. In some systems, the implantable cardiac defibrillator can be configured to sense various physiological parameters occurring in the atria and/or ventricles of the body to determine the occurrence of any abnormalities in the operation of the patient's heart. Based on these sensed parameters, an appropriate therapy may then be delivered to the patient.
[0004] Present techniques used for detecting events occurring within the heart are sometimes ineffective at discriminating between subtle differences in electrical heart activity, which can affect the type of treatment provided to the patient. In the detection of an event such as ventricular tachycardia (VT), for example, many present techniques are unable to accurately differentiate the event from another event such as a wide-complex supraventricular tachycardia (SVT), which often appears similar to ventricular tachycardia on an electrocardiogram (ECG) or electrogram (EGM). In contrast to ventricular tachycardia, the occurrence of supraventricular tachycardia may not be problematic, and may entail a different, less drastic form of therapy. Ventricular tachycardia, on the other hand, is a potentially lethal condition, and requires immediate medical therapy often in the form of shock therapy.
[0005] To discriminate between these events, many IMDs utilize interval-based and/or morphology-based algorithms, which rely on the analysis of electrical signals from an ECG or EGM. In some cases, the presence of electrical noise or interference within the body due to the pacing artifact (e.g., noise generated by a pacemaker) or from other sources may affect the ability of the sensor leads to accurately detect signals. While such techniques are effective in detecting certain types of events, they are sometimes ineffectual in discriminating between events such as ventricular tachycardia and supraventricular tachycardia.
[0006] The present disclosure relates to systems and methods of performing rhythm discrimination within the body based on sensed hemodynamic signals. In some embodiments, the method includes the steps of receiving an electrical activity signal from an electrode located within or adjacent to the heart, detecting an event of the heart based on the received electrical activity signal, sensing one or more mechanical measurements using a sensor located within the body, analyzing a mechanical activity signal received from the sensor, and confirming the event detected based on an analysis of the mechanical and electrical activity signals. In some embodiments, the sensor comprises a single pressure sensor implanted at a location within the body such as the main pulmonary artery, and is configured to sense both atrial contractions and ventricular contractions of the heart. Based on the type of event confirmed by analyzing the mechanical and electrical signals, an appropriate type of therapy may then be provided to the patient.
BRIEF DESCRIPTION OF THE DRAWINGS [0008] FIG. 1 is a schematic view of an illustrative system for providing cardiac rhythm management to a patient;
[0009] FIG. 2 is a flow chart showing an illustrative method of rhythm discrimination within the body using sensed hemodynamic signals;
[0010] FIG. 3 is a flow chart showing an illustrative method of monitoring atrial-ventricular mechanical synchrony within the heart using sensed hemodynamic signals;
[0011] FIG. 4 is a flow chart showing another illustrative method of monitoring atrial-ventricular mechanical synchrony within the heart using sensed hemodynamic signals;
[0012] FIGS. 5A-5B include a graphical readout showing several illustrative electrical and mechanical readings sensed within a patient during an arrhythmia event; and
[0013] FIG. 6 is another view of the graphical readout of FIG. 5A showing an open atrial mechanical window placed on a fiducial point of the readout.
DETAILED DESCRIPTION [0015] FIG. 1 is a schematic view of an illustrative system 10 for providing cardiac rhythm management to a patient. In the embodiment of FIG. 1, the system 10 includes a pulse generator 16 implanted within the body at a location below the patient's skin, and a remote sensor 20 implanted deeply within the patient's body such as in one of the arteries or ventricles of the patient's heart 22 or in one of the pulmonary arteries such as the main pulmonary artery 34, as shown. The heart 22 includes a right atrium 24, a right ventricle 26, a left atrium 28, and a left ventricle 30. The right ventricle 26 includes an outflow tract 32, which leads to the main pulmonary artery 34.
[0016] The pulse generator 16 can be implanted subcutaneously within the body, typically at a location such as in the patient's chest or abdomen, although other implantation locations are possible. In the illustrative CRM system 10 depicted, the pulse generator 16 is coupled to a lead 36 deployed in the patient's heart 22. A proximal portion 38 of the lead 36 can be coupled to or formed integrally with the pulse generator 16. A distal portion 40 of the lead 36, in turn, can be implanted at a desired location in or near the heart 22 such as the right ventricle 26, as shown. In use, an exposed electrode 42 on the distal portion 40 of the lead 36 may provide therapy to the patient in the form of an electrical current to the heart 22.
[0017] Although the illustrative system 10 depicts only a single lead 36 inserted into the patient's heart 22, the system 10 may include multiple leads so as to electrically stimulate other areas of the heart 22. In some embodiments, for example, the distal portion of a second lead (not shown) may be implanted in the right atrium 24 for providing electrical stimulation to the atrium 24. In addition, or in lieu, another lead may be implanted in or near the left side of the heart 22 (e.g., in the coronary veins) to stimulate the left side of the heart 22. Other types of leads such as epicardial leads may also be utilized in addition to, or in lieu of, the lead 36 depicted in FIG. 1.
[0018] During operation, the lead 36 can be configured to convey electrical signals between the pulse generator 16 and the heart 22. In those embodiments where the pulse generator 16 is a pacemaker, for example, the lead 36 can be utilized to deliver electrical therapeutic stimulus for pacing the heart 22. In those embodiments where the pulse generator 16 is an implantable cardiac defibrillator, the lead 36 can be utilized to provide electric shocks to the heart 22 in response to an event such as ventricular tachycardia or bradycardia. In some embodiments, the pulse generator 16 includes both pacing and defibrillation capabilities.
[0019] The sensor 20 can be configured to perform one or more designated functions, including the sensing of one or more physiological parameters within the body. Example physiological parameters that can be measured using the sensor 20 include, but are not limited to, blood pressure, blood flow, temperature, and strain. Various electrical, chemical and/or magnetic properties may also be sensed within the body via the sensor 20. The specific configuration and function of the sensor 20 will typically vary depending on the particular therapeutic needs of the patient. In one embodiment, for example, the sensor 20 comprises a single pressure sensor implanted at a location deep within the body such as in the main pulmonary artery 34 or a branch of the main pulmonary artery 34 (e.g., in the right or left pulmonary artery). An illustrative pressure sensor suitable for use in sensing mechanical activity within the body is described, for example, in U.S. Pat. No. 6,764,446, entitled “Implantable Pressure Sensors and Methods for Making and Using Them,” the contents of which is incorporated herein by reference in its entirety. In other embodiments, however, the sensor 20 can be implanted at other locations within the body, and can be configured to measure other parameters. Examples of other implantation locations can include, but are not limited to, the right atrium 24, the right ventricle 26, the left atrium 28, the left ventricle 30, or the coronary arteries. An example sensor that can be anchored within the body is described in U.S. Patent application Ser. No. 11/855,725, entitled “Anchor For An Implantable Sensor,” the contents of which is incorporated herein by reference in its entirety.
[0020] In the illustrative embodiment of FIG. 1, a single sensor 20 is used to simultaneously sense mechanical activity occurring within both the right atrium 24 and the right ventricle 26 of the heart 22. In some embodiments, the sensor 20 is a wireless sensor in communication with the pulse generator 16 via an acoustic, inductive, or RF telemetry link. In the illustrative system 10 depicted, for example, the pulse generator 16 includes an ultrasonic transducer 44 in acoustic communication with an ultrasonic transducer 46 coupled to the sensor 20, which together permit bidirectional wireless communications between the sensor 20 and pulse generator 16. In other embodiments, the sensor 20 is connected to the pulse generator 16 via a wired connection such as a lead.
[0021] The mechanical activity signals received from the sensor 20 can be used to confirm the existence of an electrical event detected by sense electrodes implanted within or adjacent to the heart 22, and to differentiate between types of aberrant events occurring within the heart 22. For example, in some embodiments the mechanical activity sensed by the sensor 20 can be used in conjunction with electrical activity signals received by the pulse generator 16 (e.g., from a sense electrode implanted at or near the sinus (SA) node or atrioventricular (AV) node) to differentiate between a ventricular tachycardia event versus a supraventricular tachycardia event, between a hemodynamically perfused versus non-perfused tachyarrhythmia event, or other such event.
[0022] The sensor 20 can be used in conjunction with the pulse generator 16 to optimize pacing and/or defibrillation therapy, to predict decompensation of a heart failure patient, or to provide other monitoring and/or therapy functions. In certain embodiments, for example, the sensor 20 is utilized in conjunction with an ICD to provide cardiac defibrillation to the patient as needed. Other devices such as a pulmonary sound sensor, satellite pacing device, or other such sensing and/or therapy-delivering device may also be used in conjunction with the pulse generator 16 and sensor 20.
[0023] The pulse generator 16 includes a control unit 48 which receives the electrical signals from the various leads and sensors and transmits an appropriate therapy to the patient in response. In some embodiments, the control unit 48 is configured to run a control algorithm 50 which, as discussed further herein, can be used to analyze the electrical and mechanical signals to determine the presence of an arrhythmic event such as a tachycardia or bradycardia, or for performing other rhythm discrimination within the heart.
[0024] FIG. 2 is a flow chart showing an illustrative method 52 of performing rhythm discrimination within a patient's body using sensed hemodynamic signals from the sensor 20 of FIG. 1. In the illustrative embodiment of FIG. 2, the method 52 begins generally at blocks 54 and 56 with the steps of receiving an electrical signal from a sense electrode implanted in or near the heart and detecting the presence of an event within the body. In certain embodiments, for example, electrical signals received from an electrode inserted at or near the sinoatrial (SA) node of the heart are analyzed by the control unit 48 to determine the presence of an event such as an arrhythmia. An example event that can be detected in some embodiments is the occurrence of a sudden acceleration of the patient's heart rate in which a majority of the heart beats are faster than a preset threshold level for a preset duration. The detection of an event may occur by analyzing electrical activity at other locations in or near the heart such as in the heart muscle of the right ventricle.
[0025] Once an event is detected (block 56), the sensor 20 may be activated (block 58) and tasked to take measurements of the mechanical activity within the heart to confirm the presence of the event and/or to ascertain more information about the particular event. Activation of the sensor 20 can occur, for example, when an event such as tachyarrhythmia is suspected based upon an analysis of the electrical signals received from the electrode or electrodes tasked to monitor electrical activity within the heart. In some embodiments, activation of the sensor 20 can occur by sending a wake-up signal to the sensor 20, causing the sensor 20 to switch between an initial, low-power state to an active, sensing state. In one embodiment, for example, the wake-up signal comprises a wake-up signal such as that described in U.S. Pat. No. 6,628,989 to Penner et al., entitled “Acoustic Switch and Apparatus and Methods For Using Acoustic Switches Within A Body,” the contents of which is incorporated herein by reference in its entirety. Once activated, the sensor 20 can be configured to take measurements continuously, periodically, or at predetermined intervals.
[0026] In some embodiments, a single sensor 20 may be employed to simultaneously sense both the atrial and ventricular mechanical activity within the heart (block 62), and then provide a single mechanical signal (64) to the pulse generator 16 that is then analyzed by the algorithm 50 to determine the hemodynamic status of the heart. In other embodiments, the sensor 20 is configured to sense mechanical activity in only one of the right atria or right ventricle. An example pressure sensor capable of sensing such mechanical activity is described in U.S. Pat. No. 6,140,740 to Portal et al., entitled “Piezoelectric Transducer,” the contents of which is incorporated herein by reference in its entirety. Other types of sensors capable of detecting mechanical activity within the heart can also be utilized. Other types of sensors suitable for use in sensing mechanical activity within the body can include, but are not limited to, accelerometers, motion sensors, flow sensors, and temperature sensors.
[0027] From the mechanical activity signals received from the sensor 20, the control algorithm 50 analyzes the sensed mechanical activity within the heart to confirm the presence of the event detected by the sensed electrical activity (block 66). In some embodiments, the sensed mechanical activity can also be utilized to discriminate between different types of events. If from the sensed electrical signal the control unit 48 detects the presence of a tachycardia event, for example, the sensed mechanical activity signal from the sensor 20 can be used to determine whether the tachycardia is hemodynamically unstable and requires treatment in the form of an electrical shock, or is hemodynamically stable and may require other alternative forms of therapy or treatment.
[0028] If the event detected within the heart is confirmed by mechanical activity sensed by the sensor 20, the pulse generator 16 may then determine whether therapy is indicated for the confirmed event. If it is determined that therapy is desired, the pulse generator 16 can then deliver an appropriate treatment to the patient (block 68). If, on the other hand, the event is not confirmed by the sensed mechanical activity, or if the control algorithm 50 determines that therapy is not desired, the algorithm 50 may store the event in memory and sense one or more additional electrical and/or mechanical activity readings (block 70). In some embodiments, for example, if an event is falsely identified from the sensed electrical activity, the pulse generator 16 can be configured to take one or more additional readings from the sensor 20 to determine whether the event is indicative of another problem. The ability to discern this information in real-time from the sensed mechanical activity potentially reduces the number of inappropriate shocks the patient receives, improving patient comfort and health and extending the battery life of the pulse generator 16. Complications that could result from long-term over shocking and other forms of aggressive treatment are also ameliorated based on the reduction in false positives confirmed from the sensed mechanical activity.
[0029] The methods described herein may be used in any number of applications where rhythm discrimination within the heart or at other locations within the body is desired. In some embodiments, and as discussed further herein, the methods may be used for monitoring atrial-ventricular mechanical synchrony during an arrhythmia episode, distinguishing between symptomatic tachycardias and asymptomatic tachycardias, providing hemodynamic stability and perfusion information of the heart, as well as other information. Other heart-related applications where rhythm discrimination may be useful include, but are not limited to, CRT optimization, rate responsive pacing for bradycardia applications, ischemia detection, and drug titration applications. Other treatment locations within the body may also benefit from such rhythm discrimination. In one alternative embodiment, for example, such rhythm discrimination can be used to detect the presence of blood clots within a blood vessel such as in the coronary arteries.
[0030] FIG. 3 is a flow chart showing an illustrative method 72 of monitoring atrial-ventricular (A/V) mechanical synchrony within the heart using sensed hemodynamic signals. In the embodiment of FIG. 3, the method 72 begins at block 74 with the step of receiving an electrical signal from a sense electrode implanted in or near the heart and detecting the presence of an arrhythmia event of the heart. In certain embodiments, the electrical signals can be received from a sense electrode inserted at or near the sinoatrial (SA) node of the heart. In addition, or in lieu, the electrical signals can be obtained from other locations in or near the heart such as in the right ventricle or the main pulmonary artery.
[0031] The electrical activity signals received from the sense electrodes can be fed to the control unit algorithm 50, which then analyzes these signals to detect the presence of an arrhythmia (block 76). For example, if the algorithm 50 determines that the patient's heart rate exceeds some predetermined level (e.g., 120 bpm) for a predetermined period of time (e.g., 5 seconds), the control unit 48 may conclude that the event is tachycardia.
[0032] Once a suspected event is detected, the sensor 20 may then be activated (block 78) and tasked to take measurements of the mechanical activity within the heart to confirm the presence of the event and/or to ascertain more information about the particular event (block 80). In some embodiments, for example, the pulse generator 16 sends a signal to a pressure sensor located within a pulmonary artery, causing the pressure sensor to begin taking pressure readings within the artery.
[0033] Based on the mechanical activity signals received from the sensor, the algorithm 50 analyzes (block 82) the sensed mechanical activity within the heart to confirm the presence of the event. In some embodiments, analysis of the mechanical activity signals includes the step (block 84) of comparing the right atrial and right ventricular contraction rates during an arrhythmia episode in order to verify the type of arrhythmia event occurring. If, for example, the ventricle contracts at a faster rate than the atrium for a certain number of cycles over a predetermined time period (e.g., greater than 10 cycles per minute), or, if the intervals between the ventricular contractions are regular, the algorithm 50 may conclude that the event is ventricular tachycardia (block 86). If the ventricle does not contract at a faster rate than the atrium over a predetermined time, or if the intervals between ventricular contractions are irregular, the algorithm 50 may conclude that the detected event is supraventricular tachycardia (block 88).
[0034] Depending on the type of arrhythmia detected, the pulse generator 16 may then deliver an appropriate treatment to the patient. For example, if the detected event is ventricular tachycardia, the pulse generator 16 can deliver an electric shock to the patient in the form of electrical cardioversion (e.g., synchronized cardioversion). If the detected event is supraventricular tachycardia, the pulse generator 16 can deliver an alternative form of therapy such as rate responsive pacing or drug titration. The type of therapy or treatment provided will often depend on the type of event detected, the frequency of the event, as well as other factors.
[0035] If the suspected event is not confirmed by the sensed mechanical activity, the algorithm 50 may store the event in memory and sense one or more additional electrical and/or mechanical activity readings. For example, if a suspected ventricular tachycardia event is falsely identified from the sensed electrical activity, the pulse generator 16 can be configured to ascertain one or more additional readings from the sensor 20 to determine whether the event is indicative of another problem.
[0036] FIG. 4 is a flow chart showing another illustrative method 90 of monitoring atrial-ventricular mechanical synchrony within the heart using sensed hemodynamic signals. The method 90 of FIG. 4 is similar to that described with respect to FIG. 3, beginning at block 92 with the step of receiving an electrical activity signal from a sense electrode implanted in or near the heart. The electrical activity signals received from the implanted sense electrodes can be fed to the algorithm 50 for the control unit 48, which then analyzes the electrical activity signals to detect the presence of an arrhythmia (block 94) such as, for example, tachycardia.
[0037] Once a suspected event is detected, the sensor 20 may then be activated (block 96) and tasked to take measurements of the mechanical activity within the heart to confirm the presence of the event and/or to ascertain more information about the particular event (block 98). In some embodiments, for example, the pulse generator 16 sends a signal to a pressure sensor located within a pulmonary artery, causing the pressure sensor to take pressure readings within the artery.
[0038] Based on the mechanical activity signals received from the sensor, the algorithm 50 is configured to analyze (block 100) the sensed mechanical activity within the heart to confirm the presence of the event. In the illustrative embodiment of FIG. 4, analysis of the mechanical activity signals from the sensor 20 includes the step (block 102) of comparing the atrium-ventricle (AN) mechanical delay during the arrhythmia episode in order to verify the type of arrhythmia occurring. If, for example, the atrial-ventricular association is attenuated (block 102) such that there is an atrial-ventricular dissociation and the ventricular mechanical signal occurs before the atrial event, the algorithm 50 may conclude that the detected event is a ventricular tachycardia event (block 104). Conversely, if a fast atrial contraction occurs while a relatively maintained or constant AV association is present (block 106), the algorithm 50 may conclude that the detected event is a supraventricular tachycardia event (block 108). If the suspected event is not confirmed by the sensed mechanical activity, the algorithm 50 may store the event in memory and sense one or more additional electrical and/or mechanical activity readings to determine whether the event is indicative of another problem (block 110).
[0039] FIGS. 5A-5B include a graphical readout 112 showing exemplary electrical and mechanical readings sensed within a patient during an arrhythmia event. The readout 112 may represent, for example, a number of ECG or EGM electrical activity output signals received from electrodes implanted within the right atrium and right ventricle of the heart, and various mechanical activity output signals received from pressure sensors implanted in the left ventricle, right ventricle, and right atrium of the heart.
[0040] As shown in a first electrical output waveform 114 in FIG. 5A, which represents a voltage signal output (in mV) from an electrode implanted within the right atrium of the heart, the beginning of an arrhythmic event within the heart can be seen at point 116 along the waveform 114, which shows a rapid increase in voltage indicating a possible arrhythmic episode such as ventricular tachycardia or supraventricular tachycardia. The rapid increase in voltage at point 116 represents the electrical depolarization occurring within the heart. The occurrence of the event can be further seen with respect to a second electrical output waveform 118 in FIG. 5A, which represents a voltage signal output (in mV) from a second electrode implanted within the right ventricle of the heart. In the second output waveform 118 produced by the right ventricle sensor, the beginning of the event can be seen at point 120, which is delayed from point 116 on the first output waveform 114 due to the inherent signal delay from the sinus (SA) node to the atrioventricular (AV) node.
[0041] The graphical readout 112 further illustrates the mechanical activity occurring at various locations within the heart. A first mechanical activity output waveform 122, for example, represents the mechanical pressure (mmHg) from a pressure sensor implanted within the left ventricle. A second mechanical activity output waveform 124 represents the mechanical pressure (mmHg) from a pressure sensor implanted within the right ventricle. A third mechanical activity output waveform 126, in turn, represents the mechanical pressure (mmHg) from a pressure sensor implanted within a pulmonary artery. A fourth mechanical output waveform 127 represents the aortic pressure (mmHg) within the heart.
[0042] As can be seen from the pulmonary artery output waveform 126, the pulmonary artery pressure drops synchronously with the atrial contraction of the heart. As sensed from a single pressure sensor in the pulmonary artery, this contraction can be seen at a first point 128 along the waveform 126, which shows the timing association of the atrial contraction relative to the electrical signal at point 116 in waveform 114. At point 128, the pressure within the pulmonary artery increases slightly due to the atrial contraction, and then decreases until it reaches a second point 130, which indicates the beginning of the ventricular contraction.
[0043] As further shown in an exploded view of the mechanical activity output waveform 126 in FIG. 5B, the difference in time ΔTAC between points 128 and 130 represents the duration in which atrial contraction of the heart occurs. The difference in pressure APAC between points 128 and 130 represents the change in pressure occurring over this time period. From this information, an atrial contraction rate (ACR) can be determined generally by the following expression:
[0000] Atrial contraction rate (ACR)=ΔPAC/ΔTAC.
[0044] The rate of ventricular contraction can also be ascertained from the pulmonary artery pressure sensor signal in a similar manner by comparing the rate at which the ventricular contraction occurs at the point in which the ventricular pressure increases. This period of contraction in the ventricle can be seen between points 130 and 132 on the output waveform 126. As with the atrial contraction rate, the ventricular contraction rate (VCR) can be determined from the change in pressure ΔPVC from points 130 to 132 divided by the change in time ΔTVC between points 130 and 132. This can be seen from the following expression:
[0000] Ventricular contraction rate (VCR)=ΔPVC/ΔTVC.
[0045] In some embodiments, the step (block 84) in FIG. 3 of comparing the right atrial and right ventricular contraction rates during an arrhythmia episode includes the step of computing the atrial contraction rate (ACR) and ventricular contraction rate (VCR) from the above expressions, and then comparing these mechanical contraction rates to determine the type of arrhythmia event initially detected from the electrical output waveform 114. If, for example, the ventricular contraction rate (VCR) is greater than the atrial contraction rate (ACR), the algorithm 50 for the control unit 48 may conclude that the event is ventricular tachycardia (block 86). If the ventricle does not contract a faster rate than the atrium, the algorithm 50 may conclude that the detected event is supraventricular tachycardia (block 88).
[0046] A comparison of the mechanical delays occurring during the arrhythmic event can also be used to determine the type of arrhythmia detected from the electrical output waveform 114. In the method 90 described above with respect to FIG. 4, for example, the steps 102,106 of comparing the atrium-ventricular (A/V) mechanical delay during the arrhythmia episode can include computing the delay at which atrial contraction begins at point 128 with the time at which ventricular contraction begins at point 130 on the output waveform 126. Using either of the electrical output waveforms 114, 118, the algorithm 50 may then compute an atrium-ventricular (A/V) delay during the event to determine the type of arrhythmia occurring. If, for example, the relative delays between when atrial contraction begins and ventricular contraction begins is relatively short, the algorithm 50 may conclude that the detected event is a ventricular tachycardia event (block 104). Conversely, if a fast atrial contraction occurs while a relatively maintained or constant AV association is present, the algorithm 50 may conclude that the detected event is a supraventricular tachycardia event (block 108).
[0047] In some embodiments, the algorithm 50 is configured to monitor atrial and/or ventricular electromechanical activity to determine the presence of an event within the patient's heart. In one embodiment, for example, the algorithm 50 may compare the time at which the arrhythmia occurs, as indicated generally at point 116 on the electrical output waveform 114, with the timing of the atrial and ventricular contractions sensed by the pulmonary artery sensor. Such monitoring of the electromechanical activity can be used, for example, to indicate the presence of other events and/or activity occurring within the patient's body. In some embodiments, for example, the monitoring of such electromechanical activity can be used to detect an electrolyte imbalance within the patient or to detect the occurrence of heart decompensation or heart failure.
[0048] To increase the sensitivity of the mechanical sensing, and in some embodiments, the algorithm 50 may use an open atrial mechanical window to isolate a sequence of events for analysis. As further shown in FIG. 6, for example, an open atrial mechanical window 134 can be placed at a fiducial point 136 on the readout 112 such as at the end of systole or atrial EGM. The window 134 can be configured to close or terminate at point 138 after a predetermined period of time (e.g., 75 ms, 100 ms, 125 ms, etc.) has elapsed and/or until at such point a particular event has been detected. In some embodiments, the algorithm 50 may select a window 134 for analysis based on the detection of a previous event or based on a suspected event.
Patent CitationsCited PatentFiling datePublication dateApplicantTitleUS3310885 *Jun 4, 1964Mar 28, 1967Alderson Samuel WRadio-therapy phantomUS3568661 *Oct 2, 1968Mar 9, 1971Us Health Education & WelfareFrequency modulated ultrasound technique for measurement of fluid velocityUS3794840 *Mar 27, 1972Feb 26, 1974Charlotte Memorial HospitalMethod and apparatus for directing a radiation beam toward a tumor or the likeUS3943915 *Nov 29, 1974Mar 16, 1976Motorola, Inc.Intracranial pressure sensing deviceUS4003379 *Sep 24, 1975Jan 18, 1977Ellinwood Jr Everett HApparatus and method for implanted self-powered medication dispensingUS4146029 *May 31, 1977Mar 27, 1979Ellinwood Jr Everett HSelf-powered implanted programmable medication system and methodUS4585004 *Jun 1, 1984Apr 29, 1986Cardiac Control Systems, Inc.Heart pacing and intracardiac electrogram monitoring system and associated methodUS4651740 *Feb 19, 1985Mar 24, 1987Cordis CorporationImplant and control apparatus and method employing at least one tuning forkUS4653508 *Jan 23, 1981Mar 31, 1987Cosman Eric RPressure-balanced telemetric pressure sensing system and method thereforeUS4660568 *Jan 23, 1981Apr 28, 1987Cosman Eric RTelemetric differential pressure sensing system and method thereforeUS4719921 *Aug 28, 1985Jan 19, 1988Raul ChirifeCardiac pacemaker adaptive to physiological requirementsUS4809697 *Oct 14, 1987Mar 7, 1989Siemens-Pacesetter, Inc.Interactive programming and diagnostic system for use with implantable pacemakerUS4899752 *Jun 3, 1988Feb 13, 1990Leonard BloomSystem for and method of therapeutic stimulation of a patient's heartUS4909259 *Apr 21, 1989Mar 20, 1990Tehrani Fleur TMethod and apparatus for determining metabolic rate ratioUS4986270 *May 4, 1989Jan 22, 1991Leonard BloomHemodynamically responsive system for and method of treating a malfunctioning heartUS4991579 *Nov 10, 1987Feb 12, 1991Allen George SMethod and apparatus for providing related images over time of a portion of the anatomy using fiducial implantsUS4995068 *Oct 2, 1989Feb 19, 1991S&S Inficon, Inc.Radiation therapy imaging apparatusUS4995398 *Apr 30, 1990Feb 26, 1991Turnidge Patrick ACoronary angiography imaging systemUS5003976 *Sep 28, 1988Apr 2, 1991Eckhard AltCardiac and pulmonary physiological analysis via intracardiac measurements with a single sensorUS5178151 *Sep 16, 1991Jan 12, 1993Sackner Marvin ASystem for non-invasive detection of changes of cardiac volumes and aortic pulsesUS5178153 *Feb 25, 1985Jan 12, 1993Einzig Robert EFluid flow sensing apparatus for in vivo and industrial applications employing novel differential optical fiber pressure sensorsUS5183051 *Jan 14, 1991Feb 2, 1993Jonathan KraidinMeans and apparatus for continuously determining cardiac output in a subjectUS5188106 *Mar 8, 1991Feb 23, 1993Telectronics Pacing Systems, Inc.Method and apparatus for chronically monitoring the hemodynamic state of a patient using doppler ultrasoundUS5190035 *Apr 17, 1986Mar 2, 1993Cardiac Pacemakers, Inc.Biomedical method and apparatus for controlling the administration of therapy to a patient in response to changes in physiological demandUS5277191 *Jun 19, 1991Jan 11, 1994Abbott LaboratoriesHeated catheter for monitoring cardiac outputUS5279309 *Jul 27, 1992Jan 18, 1994International Business Machines CorporationSignaling device and method for monitoring positions in a surgical operationUS5279607 *May 30, 1991Jan 18, 1994The State University Of New YorkTelemetry capsule and processUS5289821 *Jun 30, 1993Mar 1, 1994Swartz William MMethod of ultrasonic Doppler monitoring of blood flow in a blood vesselUS5394329 *Apr 27, 1993Feb 28, 1995Lucas Industries Public Limited CompanyMethod of and apparatus for estimating surface frictionUS5400793 *Jan 28, 1992Mar 28, 1995Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek TnoMethod of determining the stroke volume and the cardiac output of the human heartUS5488954 *Sep 9, 1994Feb 6, 1996Georgia Tech Research Corp.Ultrasonic transducer and method for using sameUS5490962 *Oct 18, 1993Feb 13, 1996Massachusetts Institute Of TechnologyPreparation of medical devices by solid free-form fabrication methodsUS5604531 *Jan 17, 1995Feb 18, 1997State Of Israel, Ministry Of Defense, Armament Development AuthorityIn vivo video camera systemUS5704352 *Nov 22, 1995Jan 6, 1998Tremblay; Gerald F.Implantable passive bio-sensorUS5705753 *Jun 6, 1995Jan 6, 1998Caldon, Inc.Apparatus for determining fluid flowUS5728281 *Nov 13, 1996Mar 17, 1998Pacesetter AbImplantable medical device including an arrangement for measuring a blood property having a carbon reference electrodeUS5729129 *Jun 7, 1995Mar 17, 1998Biosense, Inc.Magnetic location system with feedback adjustment of magnetic field generatorUS5733313 *Aug 1, 1996Mar 31, 1998Exonix CorporationRF coupled, implantable medical device with rechargeable back-up power sourceUS5855609 *Jan 20, 1995Jan 5, 1999Lipomatrix, Incorporated (Bvi)Medical information transponder implant and tracking systemUS5856722 *Dec 23, 1996Jan 5, 1999Cornell Research Foundation, Inc.Microelectromechanics-based frequency signature sensorUS5868673 *Mar 11, 1997Feb 9, 1999Sonometrics CorporationSystem for carrying out surgery, biopsy and ablation of a tumor or other physical anomalyUS5873835 *Sep 13, 1995Feb 23, 1999Scimed Life Systems, Inc.Intravascular pressure and flow sensorUS5886267 *Oct 3, 1996Mar 23, 1999Lockheed Martin Idaho Technologies CompanySystem and method for bidirectional flow and controlling fluid flow in a conduitUS6023641 *Oct 28, 1998Feb 8, 2000Medtronic, Inc.Power consumption reduction in medical devices employing multiple digital signal processorsUS6024704 *Apr 30, 1998Feb 15, 2000Medtronic, IncImplantable medical device for sensing absolute blood pressure and barometric pressureUS6171252 *Apr 29, 1999Jan 9, 2001Medtronic, Inc.Pressure sensor with increased sensitivity for use with an implantable medical deviceUS6179767 *Feb 1, 1999Jan 30, 2001International Business Machines CorporationFocussing of therapeutic radiation on internal structures of living bodiesUS6185452 *Feb 25, 1998Feb 6, 2001Joseph H. SchulmanBattery-powered patient implantable deviceUS6198965 *May 17, 1999Mar 6, 2001Remon Medical Technologies, Ltd.Acoustic telemetry system and method for monitoring a rejection reaction of a transplanted organUS6200265 *Apr 16, 1999Mar 13, 2001Medtronic, Inc.Peripheral memory patch and access method for use with an implantable medical deviceUS6298267 *Mar 7, 2000Oct 2, 2001Intermedics Inc.Method and apparatus for treatment of cardiac electromechanical dissociationUS6504286 *Oct 20, 2000Jan 7, 2003Remon Medical Technologies Ltd.Piezoelectric transducerUS6522914 *Jul 14, 2000Feb 18, 2003Cardiac Pacemakers, Inc.Method and apparatuses for monitoring hemodynamic activities using an intracardiac impedance-derived parameterUS6615083 *Apr 27, 2001Sep 2, 2003Medtronic, Inc.Implantable medical device system with sensor for hemodynamic stability and method of useUS6675049 *Jul 17, 2001Jan 6, 2004Medtronic, Inc.Method and apparatus for automatic implantable medical lead recognition and configurationUS6699186 *Mar 10, 2000Mar 2, 2004Remon Medical Technologies LtdMethods and apparatus for deploying and implantable biosensorUS6702847 *Jun 29, 2001Mar 9, 2004Scimed Life Systems, Inc.Endoluminal device with indicator member for remote detection of endoleaks and/or changes in device morphologyUS6708061 *Dec 11, 2000Mar 16, 2004Cardiac Pacemakers, Inc.Cardiac rhythm management system with optimization of cardiac performance using heart rateUS6708065 *Mar 2, 2001Mar 16, 2004Cardiac Pacemakers, Inc.Antenna for an implantable medical deviceUS6712772 *Feb 15, 2002Mar 30, 2004Biocontrol Medical Ltd.Low power consumption implantable pressure sensorUS6840956 *Mar 10, 2000Jan 11, 2005Remon Medical Technologies LtdSystems and methods for deploying a biosensor with a stent graftUS6855115 *Jan 22, 2002Feb 15, 2005Cardiomems, Inc.Implantable wireless sensor for pressure measurement within the heartUS6859665 *Jul 7, 2003Feb 22, 2005Cardiac Pacemakers, Inc.Cardiac pacing using adjustable atrio-ventricular delaysUS6865419 *Nov 30, 2001Mar 8, 2005Medtronic, Inc.Method and apparatus for measurement of mean pulmonary artery pressure from a ventricle in an ambulatory monitorUS6868346 *Nov 27, 2002Mar 15, 2005Cardiac Pacemakers, Inc.Minute ventilation sensor with automatic high pass filter adjustmentUS6869404 *Feb 26, 2003Mar 22, 2005Medtronic, Inc.Apparatus and method for chronically monitoring heart sounds for deriving estimated blood pressureUS6871088 *Mar 20, 2003Mar 22, 2005Medtronic, Inc.Method and apparatus for optimizing cardiac resynchronization therapyUS6985773 *Feb 7, 2002Jan 10, 2006Cardiac Pacemakers, Inc.Methods and apparatuses for implantable medical device telemetry power managementUS6993393 *Dec 19, 2001Jan 31, 2006Cardiac Pacemakers, Inc.Telemetry duty cycle management system for an implantable medical deviceUS7003350 *Nov 3, 2003Feb 21, 2006Kenergy, Inc.Intravenous cardiac pacing system with wireless power supplyUS7018336 *Dec 27, 2001Mar 28, 2006Medtronic Minimed, Inc.Implantable sensor flush sleeveUS7130681 *May 9, 2003Oct 31, 2006Medtronic, Inc.Use of accelerometer signal to augment ventricular arrhythmia detectionUS7160252 *Apr 21, 2003Jan 9, 2007Medtronic, Inc.Method and apparatus for detecting respiratory disturbancesUS7181268 *Nov 25, 2002Feb 20, 2007Medtronic, Inc.Ischemia detectionUS7195594 *May 13, 2003Mar 27, 2007Pacesetter, Inc.Method for minimally invasive calibration of implanted pressure transducersUS7335161 *Aug 20, 2004Feb 26, 2008Cardiac Pacemakers, Inc.Techniques for blood pressure measurement by implantable deviceUS7481771 *Jul 7, 2004Jan 27, 2009Cardiomems, Inc.Implantable wireless sensor for pressure measurement within the heartUS20020023123 *Jul 26, 1999Feb 21, 2002Justin P. MadisonGeographic data locatorUS20030009204 *Jul 6, 2001Jan 9, 2003Amundson Mark D.Adapative telemetry system and method for an implantable medical deviceUS20030023173 *May 28, 2002Jan 30, 2003Hypertension Diagnostics, Inc.Apparatus and method for blood pressure pulse waveform contour analysisUS20030045805 *Aug 30, 2001Mar 6, 2003Medtronic, Inc.Ischemia detectionUS20030060723 *Aug 26, 2002Mar 27, 2003Medtronic Physio-Control Manufacturing Corp.Pulse detection apparatus, software, and methods using patient physiological signalsUS20040032187 *Aug 12, 2003Feb 19, 2004Remon Medical Technologies Ltd.Devices for intrabody delivery of molecules and systems and methods utilizing sameUS20040044393 *Aug 27, 2002Mar 4, 2004Remon Medical Technologies Ltd.Implant systemUS20050056539 *Oct 25, 2004Mar 17, 2005Medtronic-Minimed, Inc.Implantable sensor electrodes and electronic circuitryUS20060009818 *Jul 9, 2004Jan 12, 2006Von Arx Jeffrey AMethod and apparatus of acoustic communication for implantable medical deviceUS20060031378 *Aug 5, 2004Feb 9, 2006Vineel VallapureddySystem and method for providing digital data communications over a wireless intra-body networkUS20060064133 *Sep 17, 2004Mar 23, 2006Cardiac Pacemakers, Inc.System and method for deriving relative physiologic measurements using an external computing deviceUS20060064134 *Sep 17, 2004Mar 23, 2006Cardiac Pacemakers, Inc.Systems and methods for deriving relative physiologic measurementsUS20060064142 *Sep 17, 2004Mar 23, 2006Cardiac Pacemakers, Inc.Systems and methods for deriving relative physiologic measurements using an implanted sensor deviceUS20060064143 *Sep 17, 2004Mar 23, 2006Cardiac Pacemakers, Inc.Systems and methods for deriving relative physiologic measurements using a backend computing systemUS20070043394 *Aug 22, 2005Feb 22, 2007Cardiac Pacemakers, IncIntracardiac impedance and its applicationsUS20070049977 *Aug 26, 2005Mar 1, 2007Cardiac Pacemakers, Inc.Broadband acoustic sensor for an implantable medical deviceUS20070060959 *Sep 9, 2005Mar 15, 2007Cardiac Pacemakers, Inc.Using implanted sensors for feedback control of implanted medical devicesUS20080015421 *Sep 19, 2007Jan 17, 2008Remon Medical Technologies, Ltd.Barometric pressure correction based on remote sources of informationUS20080015651 *Jul 14, 2006Jan 17, 2008Benjamin EttoriBaroreflex sensitivity monitoring and trending for tachyarrhythmia detection and therapyUS20080021333 *Jul 20, 2007Jan 24, 2008Cardiac Pacemakers, Inc.Multiple sensor deploymentUS20080021972 *Jul 20, 2007Jan 24, 2008Cardiac Pacemakers, Inc.System and method for addressing implantable devicesUS20080046037 *Apr 24, 2007Feb 21, 2008Haubrich Gregory JWireless Communication Network for an Implantable Medical Device SystemUS20080051843 *Aug 25, 2006Feb 28, 2008Dan LiMethod and apparatus for automated adjustment of arrhythmia detection durationUS20080071178 *Sep 14, 2007Mar 20, 2008Cardiac Pacemakers, Inc.Anchor for an implantable sensorUS20080077440 *Sep 24, 2007Mar 27, 2008Remon Medical Technologies, LtdDrug dispenser responsive to physiological parameters* Cited by examinerReferenced byCiting PatentFiling datePublication dateApplicantTitleUS7949394May 24, 2011Cardiac Pacemakers, Inc.Using implanted sensors for feedback control of implanted medical devicesUS7955268Jul 20, 2007Jun 7, 2011Cardiac Pacemakers, Inc.Multiple sensor deploymentUS8369960Feb 5, 2013Cardiac Pacemakers, Inc.Systems and methods for controlling wireless signal transfers between ultrasound-enabled medical devicesUS8417336May 26, 2010Apr 9, 2013Cardiac Pacemakers, Inc.System and method for pacing rate control utilizing patient hemodynamic status informationUS8423140Apr 16, 2013Cardiac Pacemakers, Inc.System and method for decompensation detection and treatment based on patient hemodynamicsUS8478392Jun 24, 2011Jul 2, 2013Cardiac Pacemakers, Inc.Rhythm discrimination using information indicative of lead motionUS8532770Jun 24, 2011Sep 10, 2013Cardiac Pacemakers, Inc.Cardiac mechanical vibration monitor using information indicative of lead motionUS8583232 *Apr 8, 2013Nov 12, 2013Cardiac Pacemakers, Inc.System and method for pacing rate control utilizing patient hemodynamic status informationUS8591423Sep 10, 2009Nov 26, 2013Cardiac Pacemakers, Inc.Systems and methods for determining cardiac output using pulmonary artery pressure measurementsUS8632470Sep 24, 2009Jan 21, 2014Cardiac Pacemakers, Inc.Assessment of pulmonary vascular resistance via pulmonary artery pressureUS8649853Jun 24, 2011Feb 11, 2014Cardiac Pacemakers, Inc.Cardiac function monitor using information indicative of lead motionUS8738111Jun 24, 2011May 27, 2014Cardiac Pacemakers, Inc.Cardiac contraction detection using information indicative of lead motionUS8812102May 9, 2012Aug 19, 2014Cardiac Pacemakers, Inc.Sensor response delay for hemodynamic stability detection during arrhythmiaUS8825156Apr 12, 2013Sep 2, 2014Cardiac Pacemakers, Inc.System and method for decompensation detection and treatment based on patient hemodynamicsUS8965504Feb 28, 2013Feb 24, 2015Cardiac Pacemakers, Inc.Systems and methods of characterizing mechanical activation patterns for rhythm discrimination and therapyUS8996101 *Apr 27, 2012Mar 31, 2015Medtronic, Inc.Heart sound sensing to reduce inappropriate tachyarrhythmia therapyUS20090149766 *Oct 22, 2008Jun 11, 2009Shuros Allan CCoronary vein hemodynamic sensorUS20100305635 *May 24, 2010Dec 2, 2010Lili LiuSystem and method for rhythm identification and therapy discrimination using hemodynamic status informationUS20100305649 *Dec 2, 2010Barun MaskaraSystem and method for decompensation detection and treatment based on patient hemodynamicsUS20100305650 *May 26, 2010Dec 2, 2010Barun MaskaraSystem and method for pacing rate control utilizing patient hemodynamic status informationUS20130237873 *Apr 27, 2012Sep 12, 2013Xusheng ZhangHeart sound sensing to reduce inappropriate tachyarrhythmia therapyCN102448542A *May 24, 2010May 9, 2012心脏起搏器公司System and method for rhythm identification and therapy discrimination using hemodynamic status informationWO2010138450A1 *May 24, 2010Dec 2, 2010Cardiac Pacemakers, Inc.System and method for rhythm identification and therapy discrimination using hemodynamic status informationWO2012005987A3 *Jun 24, 2011Mar 15, 2012Cardiac Pacemakers, Inc.Rhythm discrimination using information indicative of lead motionWO2012005988A3 *Jun 24, 2011Mar 15, 2012Cardiac Pacemakers, Inc.Cardiac contraction detection using information indicative of lead motionWO2012005989A3 *Jun 24, 2011Apr 19, 2012Cardiac Pacemarkers, Inc.Cardiac function monitor using information indicative of lead motion* Cited by examinerClassifications U.S. Classification607/14, 607/23International ClassificationA61N1/365Cooperative ClassificationA61N1/36578, A61N1/36585European ClassificationA61N1/365CLegal EventsDateCodeEventDescriptionApr 1, 2009ASAssignmentOwner name: CARDIAC PACEMAKERS, INC., MINNESOTAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHUROS, ALLAN C.;LI, DAN;NI, QUAN;REEL/FRAME:022484/0468;SIGNING DATES FROM 20090114 TO 20090127Owner name: CARDIAC PACEMAKERS, INC., MINNESOTAFree format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SHUROS, ALLAN C.;LI, DAN;NI, QUAN;SIGNING DATES FROM 20090114 TO 20090127;REEL/FRAME:022484/0468RotateOriginal ImageGoogle Home - Sitemap - USPTO Bulk Downloads - Privacy Policy - Terms of Service - About Google Patents - Send FeedbackData provided by IFI CLAIMS Patent Services